ARCHIVES

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Scientific Community Rallies To Support DeVita; Immediate Suspension Of Straus’ Grant Considered

June 12, 1981

Hilton Head, SC, Physician’s Files Subpoenaed By FBI

March 18, 1994

NCI T Phase Out Support Of VA Lung Group, But Will Continue Funding VASAG

November 3, 1978

In Brief: RFPs For Recompeting Frederick Contract Still Being Drafted; Panel Meets April 13

April 10, 1981

Fraumeni Appointed field Studies Chief

January 18, 1980

Univ. Of Pittsburgh Plans Molecular Medicine Institute.

January 25, 2002